Detalhe da pesquisa
1.
Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with combined SOS1 and MEK Inhibition for Improved Immunotherapy Response.
Cancer Res Commun
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727236